SCHEMBL22044096

SCHEMBL22044096

O=C(NCc1c(F)cccc1Cl)c1cccc(-c2c[nH]c3ccccc23)c1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ROCK2 O75116 7/20 0.53
▸ ROCK1 Q13464 6/20 0.53
▸ CDK4 P11802 2/20 0.47
▸ CCND1 P24385 2/20 0.47
▸ ASH1L Q9NR48 2/20 0.46
▸ ITGB2 P05107 1/20 0.45
▸ ICAM1 P05362 1/20 0.45
▸ ITGAL P20701 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ BACE1 P56817 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ ALDH2 P05091 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ SNCA P37840 1/20 0.43
▸ MAPK14 Q16539 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22044473 0.91 ROCK2 (0.52) ROCK2ROCK1CDK4CCND1ITGB2
SCHEMBL22044875 0.87 ROCK2 (0.48) ROCK2ROCK1ITGB2ICAM1ITGAL
SCHEMBL22044123 0.85 ROCK2 (0.53) ROCK2ROCK1MAPK1MAPK14
SCHEMBL22044080 0.85 ROCK2 (0.47) ROCK2ROCK1ITGB2ICAM1ITGAL
SCHEMBL22044571 0.84 ROCK2 (0.46) ROCK2ROCK1ITGB2ICAM1ITGAL
SCHEMBL22043982 0.83 MAPK1 (0.61) ROCK2ROCK1MAPK1MAPK14
SCHEMBL22044153 0.81 MAPK14 (0.42) ROCK2ROCK1ITGB2ICAM1ITGAL
SCHEMBL22044088 0.80 ATM (0.43) ROCK2ROCK1ITGB2ICAM1ITGAL
SCHEMBL3460926 0.77 LMNA (0.64) ROCK2ROCK1SMN1; SMN2MAPTHTT
SCHEMBL22044118 0.76 CAMKK2 (0.55) ROCK2ROCK1SMN1; SMN2ALDH2MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200172521-A1 Five-Membered-Fused-Six-Membered Aza-Aromatic Ring Compound, Preparation Method Thereof, Pharmaceutical Composition And Application Thereof Amcure Biosciences Pte. Ltd. (SG) 2020-06-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200172521-A1 Five-Membered-Fused-Six-Membered Aza-Aromatic Ring Compound, Preparation Method Thereof, Pharmaceutical Composition And Application Thereof KRAS, NRAS, RASSF5 ROCK2 1660/4885ROCK1 1252/4885CDK4 369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback